CANNABIS USE DISORDER IN SCHIZOPHRENIA
This chapter provides insights into the impact of Cannabis Use Disorder (CUD) on schizophrenia symptoms and treatment, and strategies for managing both conditions. By understanding cannabis use in schizophrenia, caregivers can better support and help improve outcomes for their loved ones.
Fast Facts
Cannabis use is common among people with schizophrenia, often as a way to cope with symptoms, despite its risks of triggering psychotic episodes and interfering with treatment.
Cannabis Use Disorder goes beyond occasional use, leading to withdrawal symptoms and making it hard to quit, which further complicates schizophrenia management.
Gradually reducing or eliminating cannabis use can help prevent or even improve the symptoms of schizophrenia.
Managing together: Effective treatment requires psychiatric care, gradual cannabis reduction, and strict medication adherence. Family support is essential for better outcomes and improved quality of life.
******
About Cannabis
Cannabis, derived from the Cannabis sativa and Cannabis indica plants, has been used for thousands of years both as a material and as a psychoactive drug.
Cannabinoids are a group of substances found in the cannabis plant. The main cannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Besides THC and CBD, more than 100 other cannabinoids have been identified.
Notably, the words “cannabis” and “marijuana” are often used interchangeably, but they don’t mean the same thing. “Cannabis” refers to all products from the Cannabis sativa plant, while “marijuana” specifically includes parts with significant THC, the compound responsible for its psychoactive effects.
The most active compound in cannabis is delta-9-tetrahydrocannabinol (THC), which is known for producing a euphoric “high”.
It is important to know that THC can also trigger short-lived psychotic symptoms, even in individuals without schizophrenia disorder.
******
